Target intelligence / Profile preview

Fibrin clot structure

Molecular classification
Other (biological structure/assembly)
01

Overview

Fibrin clot structure is the organized, three-dimensional meshwork of fibrin fibers resulting from the polymerization of fibrin monomers (converted from fibrinogen by thrombin) and subsequent crosslinking by Factor XIIIa. This network mechanically stabilizes the blood clot at sites of vascular injury, entrapping platelets and blood cells to prevent blood loss and providing a scaffold for wound healing and tissue repair. The structure is hierarchical, with fibrous bundles stabilized by covalent crosslinks, and is regulated by genetic (fibrinogen variants and mutations), biochemical (thrombin concentration, Factor XIII activity), and environmental factors (inflammation, oxidative stress). The architecture of the fibrin clot—fiber thickness, branch points, and degree of crosslinking—can influence resistance to fibrinolysis (clot breakdown), stability, and disease risk for thrombotic or bleeding disorders. Abnormalities in clot structure have been implicated in arterial and venous thrombosis, myocardial infarction, stroke, and bleeding diatheses.

Other names
Fibrin networkFibrin meshBlood clot matrix
02

Biological functions

Hemostasis (prevention of blood loss)Wound healing scaffoldMechanical stabilization of clotsModulation of fibrinolysis (clot breakdown)
03

Disease associations

Cardiovascular disease (thrombosis, embolism)Bleeding disorders (impaired clot structure can lead to excessive bleeding)Inflammation (modulated by inflammatory states)
04

Biomarkers

D-dimer (degradation product, used as biomarker for clot breakdown/thrombosis)Clot permeability and lysis time (laboratory parameters for clot structure)

Beyond the preview

Go deeper on Fibrin clot structure.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fibrin clot structure.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call